Learning Objectives 2019-02-20T02:23:51+00:00

Learning Objectives

By the end of the meeting, participants will: be able to discuss new concepts in rheumatic diseases; be able to appraise new treatment paradigms and guidelines for rheumatic diseases; be able to encourage peer mentoring. The meeting will allow for clinical and scholarly collaboration, and to interact with members of the Arthritis Health Professions Association for the benefit of our patients.

Wednesday, February 27, 2019

Clinical Pearls and Mysterious Cases

Presenters ♦  Tooba Ali, Hanouf Alsaleem, Alexandra Legge, Timothy Kwok, Herman Tam

At the end of this session, participants will be able to:

  1. list clinical pearls potentially of use in their practices
  2. recognize & evaluate the clinical reasoning necessary to solve mysterious cases

CanMeds roles

  1. Medical Experts
  2. Collaborators

National Update

Position Statement: A Pragmatic Approach for Medical Cannabis and Patients with Rheumatic Diseases ♦ Omid Zahedi

Cannabis has been legalized in Canada and physicians, especially rheumatologists, must be ready to offer pragmatic advice to patients currently using or requesting to use cannabis for medical purposes. This position statement emphasizes harm reduction and promotes discussion and research on the subject.

At the end of this session, participants will be able to:

  1. assess for absolute and relative contraindications to medical cannabis use
  2. develop a structured approach to initiating a trial of medical cannabis
  3. provide pragmatic advice and effectively counsel patients on the potential harms and benefits associated with medical cannabis use

CanMeds roles

Project ECHO Rheumatology: The Call for Capacity-building Reverberates ♦ Amanda Steiman

Project ECHO Rheumatology (Ontario) was developed to build capacity for the provision of timely and appropriate rheumatologic care. This session provides an update on Project ECHO’s progress to date and shares its vision for the future.

At the end of this session, participants will be able to:

  1. describe the ECHO model
  2. understand the goals of Project ECHO Rheumatology
  3. understand the impact of Project ECHO Rheumatology to date, and be apprised of its future directions

Update on the CRA/AAC/CATCH Collaboration – “Cost-Consequences Analysis of Models of Care for Patients with Inflammatory Arthritis” Project ♦ Deborah Marshall

Our collaborative project with CRA/AAC/CATCH on the “Cost-Consequences Analysis of Models of Care for Patients with Inflammatory Arthritis” aims to explore characteristics of examples of existing models of care for patients with Inflammatory Arthritis in Canada. We will assess the associated quality of care and costs to identify factors that contribute to a successful model of care in the Canadian environment. During this presentation, we will present progress of the initiative to date, preliminary results of the qualitative phase of the research, and the next steps.

At the end of this session, participants will be able to:

  1. describe the context and motivation for initiating this national collaborative initiative, its objectives, partners, participants and anticipated outcomes
  2. describe how this work will identify best practices for multidisciplinary models of care for patients with inflammatory arthritis that are translatable and advocate funding for these models of care
  3. be informed about the next steps and timelines and consider how these findings might apply in their own practice setting

CATCH:  Building Bridges Across Canada ♦ Vivian Bykerk

The Canadian Early Arthritis Cohort Study (CATCH) is a Canadian multi-centre research study that aims to improve the quality of care for people with early inflammatory arthritis. This session provides an update on CATCH Participants & Sites, it’s Scientific Network, Research Database and Outcomes.

At the end of this session, participants will be able to:

  1. understand the mission and vision of CATCH
  2. be aware of the breadth of CATCH’s research platform and the opportunities for collaboration to build bridges with other groups
  3. describe findings that support best practices per Canadian RA Recommendations

Keynote Lecture by Andre Picard: Quirky Past, Uncertain Future: The State of Medicare in Canada

An examination of the challenges faced by Canada’s health system – past, present and future.

At the end of this session, participants will be able to:

  1. enhance knowledge of the pros and cons of Canada’s medicare system through an examination its history
  2. discuss the financial, political and administrative barriers to reforming Canada’s health system
  3. reflect on the necessary systemic changes required

CanMeds roles

  1. Communicators
  2. Leaders
  3. Health Advocates

 

Thursday, February 28, 2019

Podium Presentations

Presenters ♦ Laura Passalent, Carolina Munoz-Grajalesm, Bindee Kuriya, Dario Ferri,  Ines Colmegna, Lauren King, Lihi Eder

At the end of this session, participants will be able to:

  1. describe clinical, basic and epidemiological research highlighted by CRA members
  2. describe recent advances in SLE research, basic science research,  and clinical epidemiological research performed by trainee members of the CRA & medical undergraduates
  3. outline the recent progress in academic rheumatology research across Canada

State of the Art Lecture by Mark Roberts: Myositis and its Mimics

Acquired myelitis and genetic myopathies can be readily confused. Clinical clues and the importance of an MDT approach is emphasized.

At the end of this session, participants will be able to:

  1. genetic myopathies often present in adulthood
  2. late onset dystrophies and myositis share many features
  3. necrotising myositis and metabolic disorders are readily confused

CanMeds roles

  1. Medical Experts
  2. Collaborators
  3. Professionals

Meet the Expert Session

Presenters ♦ Gilles Boire,  Heather McDonald-Blumer, Gus Grant,  Mark Roberts

At the end of this session, participants will be able to:

  1. compare best practices related to common practice issues
  2. identify networking connections to facilitate problem solving in practice
  3. evaluate tips to improve diagnosis and management of  rheumatic diseases

Great Debate: Be it Resolved that Competency-based Medical Education will Result in Improved Quality of Care for Patients vs the “Old Way” of Training Rheumatologists

Academic Rheumatology Programs across Canada are launching CBME in July 2019. This debate will address the pros and cons of this new curriculum and method of evaluation of our trainees.

At the end of this session, participants will be able to

  1. describe the pros and cons of CBME as it applies to rheumatology
  2. understand how academic practice will have to change to accommodate CBME
  3. develop strategies to better teach within the CBME framework

CanMeds roles

Friday, March 1, 2019

Podium Presentations

Presenters ♦ Siobhan Deshauer, Laetitia Michou, Sofia Oke, Paivi Miettunen, Dilek Solmaz, Walter Maksymowych, Kostantinos Tselios

At the end of this session, participants will be able to:

  1. describe clinical, basic and epidemiological research highlighted by CRA members
  2. describe recent advances in SLE research, basic science research,  and clinical epidemiological research performed by trainee members of the CRA & medical undergraduates
  3. outline the recent progress in academic rheumatology research across Canada

Keynote Address by Diane Lacaille, Distinguished Investigator Awardee 2019: Time to Re-label Comorbidities in RA – Coexisting or Complications?

This presentation will highlight the importance of addressing comorbidities in the care of rheumatoid arthritis and shift our conception of comorbidities from co-existing conditions to complications of RA due to systemic effects of inflammation.

At the end of this session, participants will be able to:

  1. identify the comorbidities at increased risk in RA relative to the general population
  2. discuss the quality of care received by people living with RA for comorbidities
  3. review recommendations for the management of comorbidities in RA

CanMeds roles

  1. Medical Experts
  2. Communicators
  3. Health Advocates
  4. Scholars
  5. Professionals

RheumJeopardy 2019: Bridging Knowledge Gaps Through Gamification

Based on the classic TV game show Jeopardy! Every audience member will be a player on one of 2 teams in an interactive contest testing your knowledge of rheumatology topics with a Canadian focus. Entertaining, provocative and fun!

At the end of this session, participants will be able to:

  1. highlight recent world-class Canadian research in rheumatology
  2. prove that rheumatology is the most interesting medical subspecialty
  3. build bridges within the Canadian rheumatology community through educational game play in a safe environment

CanMeds roles

  1. Medical Experts
  2. Communicators
  3. Scholars

Meet the Expert Session

Presenters ♦ Pari Basharat

At the end of this session, participants will be able to:

  1. compare best practices related to common practice issues
  2. identify networking connections to facilitate problem solving in practice
  3. evaluate tips to improve diagnosis and management of  rheumatic diseases

Saturday, March 2, 2019

Dunlop-Dottridge Lecture by Gilles Boire: The 4-H of Biomarkers in Arthritis: A lot of Help, Potential Harm, Some Hype, Increasing Hope

Biomarkers bring order into clinical chaos. Biomarkers do not stand for disease.  Novel approaches to old and new biomarkers may lead to more personalized treatments, but much remains to be done.

At the end of this session, participants will be able to:

  1. summarize the current biomarkers useful for patient care
  2. question the prevailing emphasis on biomarkers for arthritis care
  3. interpret critically the biomarkers in development

CanMeds roles

  1. Medical Experts
  2. Collaborators
  3. Scholars

CIORA Project Showcase

Self-assessment Triage in Inflammatory Arthritis: A Pilot Study ♦ Barry Koehler

This study aims to evaluate whether either or a combination of a questionnaire and patient-self assessment of painful joints will permit early identification of inflammatory arthritis in referred patients.

At the end of this session, participants will be able to:

  1. understand the value of collaboration with colleagues in carrying out a research study
  2. appreciation of the value of biostatistical advice in study design, prior to grant application
  3. understand the time commitment necessary to complete such a study

CanMeds roles

What do People Living with Rheumatoid Arthritis and their Health Care Providers Consider Barriers or Facilitators for Influenza Vaccine Uptake? ♦ Ines Colmegna

We will discuss the results of RA patients’ and health care providers’ focus groups and their implications to achieve adequate uptake of influenza vaccine.

At the end of this session, participants will be able to:

  1. understand the gaps between desired and current vaccination rates among rheumatoid arthritis (RA) patients
  2. describe facilitators of influenza vaccine acceptance among RA patients
  3. identify barriers to influenza vaccination among RA patients

CanMeds roles

 

Addressing Rural and Remote Access Disparities for Patients with Inflammatory Arthritis through Telehealth/Videoconferencing and Innovative Inter-professional Care Models ♦ Regina Taylor Gjevre

This was a randomized controlled study of RA patients from rural Saskatchewan. Study participants were allocated to traditional rheumatology clinic follow up or remote video-conferenced rheumatology follow up with physical therapist on-site examiners. Study results found no difference in specific patient outcomes between the two follow up methods.

At the end of this session, participants will be able to:

  1. describe barriers for access to rheumatology care for rural and remote populations
  2. discuss findings from an RCT for two care delivery models
  3. recognize potential secondary consequences for different care models

CanMeds roles